Overview
Availability
- Professor Scott Bell is:
- Available for supervision
Fields of research
Works
Search Professor Scott Bell’s works on UQ eSpace
2007
Journal Article
Beta-lactam allergy in adults with cystic fibrosis
Burrows, Judith A., Nissen, Lisa M., Kirkpatrick, Carl M. J. and Bell, Scott. C. (2007). Beta-lactam allergy in adults with cystic fibrosis. Journal of Cystic Fibrosis, 6 (4), 297-303. doi: 10.1016/j.jcf.2006.11.001
2007
Journal Article
Phenotypic characterization of clonal and nonclonal Psuedomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis
Tingpej, Pholawat, Smith, Lucas, Rose, Barbara, Zhu, Hua, Conibear, Tim, Al Nassafi, Khaled, Manos, Jim, Elkins, Mark, Bye, Peter, Willcox, Mark, Bell, Scott, Wainwright, Claire and Harbour, Colin (2007). Phenotypic characterization of clonal and nonclonal Psuedomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis. Journal of Clinical Microbiology, 45 (6), 1697-1704. doi: 10.1128/JCM.02364-06
2007
Journal Article
Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON®-CMV
Walker, S., Fazou, C., Crough, T., Holdsworth, R., Kiely, P., Veale, M., Bell, S. C., Gailbraith, A. J., McNeil, K., Jones, S. and Khanna, R. (2007). Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON®-CMV. Transplant Infectious Disease, 9 (2), 165-170. doi: 10.1111/j.1399-3062.2006.00199.x
2007
Journal Article
Pulmonary exacerbations in cystic fibrosis and bronchiectasis
Elborn, J. S. and Bell, S. C. (2007). Pulmonary exacerbations in cystic fibrosis and bronchiectasis. Thorax, 62 (4), 288-290. doi: 10.1136/thx.2006.065664
2007
Journal Article
A D-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients
Hennig, Stefanie, Waterhouse, Timothy H., Bell, Scott C., France, Megan, Wainwright, Claire E., Miller, Hugh, Charles, Bruce G. and Duffull, Stephen B. (2007). A D-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients. British Journal of Clinical Pharmacology, 63 (4), 438-450. doi: 10.1111/j.1365-2125.2006.02778.x
2007
Conference Publication
Does antibiotic sensitivity testing for Pseudomonas aeruginosa exacerbations in cystic fibrosis patients influence clinical choice?
Smith, H., Bell, S. and Nissen, L. (2007). Does antibiotic sensitivity testing for Pseudomonas aeruginosa exacerbations in cystic fibrosis patients influence clinical choice?. SHPA 28th Federal Conference 2007, Convention Centre, Sydney Australia, 8-11 November 2007.
2007
Journal Article
Gene-environmental interaction in asthma
Yang, Ian A., Savarimuthu, Santiyagu, Kim, Samuel T., Holloway, John W., Bell, Scott C. and Fong, Kwun M. (2007). Gene-environmental interaction in asthma. Current Opinion in Allergy & Clinical Immunology, 7 (1), 75-82. doi: 10.1097/ACI.0b013e328012ce39
2007
Conference Publication
Audit of iron infusions in the cystic fibrosis (CF) and bronchiectasis populations
Masel, P. J., Tse, T., Herd, K., Wood, P. and Bell, S. (2007). Audit of iron infusions in the cystic fibrosis (CF) and bronchiectasis populations. 7th Australasian Cystic Fibrosis Conference, Sydney, Australia, 11th - 14th August 2007.
2006
Journal Article
Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis
Smith, Lucas, Rose, Barbara, Tingpej, Pholawat, Zhu, Hua, Conibear, Tim, Manos, Jim, Bye, Peter, Elkins, Mark, Willcox, Mark, Bell, Scoot, Wainwright, Claire and Harbour, Colin (2006). Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis. Journal of Medical Microbiology, 55 (12), 1641-1644. doi: 10.1099/jmm.0.46845-0
2006
Journal Article
Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis
Buntain, H. M., Schluter, P. J., Bell, S. C., Greer, R. M., Wong, J. C. H., Batch, J., Lewindon, P. and Wainwright, C. E. (2006). Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis. Thorax, 61 (2), 146-154. doi: 10.1136/thx.2005.046516
2006
Journal Article
Epidemiological analysis of methicillin-resistant Staphylococcus aureus isolates from adult patients with cystic fibrosis
Kidd, T. J., Coulter, C. and Bell, S. C. (2006). Epidemiological analysis of methicillin-resistant Staphylococcus aureus isolates from adult patients with cystic fibrosis. Infection Control and Hospital Epidemiology, 27 (2), 201-203. doi: 10.1086/501173
2006
Conference Publication
Paediatric population pharmacokinetcis (popPK) of itraconazole (ITRA) and its active metabolite hydroxy-itraconazole in cystic fibrosis (CF) and bone marrow transplant patients (BMT)
Hennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Paediatric population pharmacokinetcis (popPK) of itraconazole (ITRA) and its active metabolite hydroxy-itraconazole in cystic fibrosis (CF) and bone marrow transplant patients (BMT). PAGANZ 06 9th Annual Scientific Meeting, Auckland New Zealand / School of Medicine, 7-9 February 2006. Brisbane, Australia: Poppulation Approach Group in Australia and New Zealand.
2006
Book Chapter
Cystic Fibrosis Infection with Clonal Strains of Pseudomonas Aeruginosa: Current Knowledge and Future Management
Jones, A. M. and Bell, S. C. (2006). Cystic Fibrosis Infection with Clonal Strains of Pseudomonas Aeruginosa: Current Knowledge and Future Management. Cystic Fibrosis. (pp. 105-126) edited by K. Webb and F. Ratjen. London: Maney Publishing.
2006
Conference Publication
Paediatric population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in cystic fibrosis and bone marrow transplant patients
Hennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006). Paediatric population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in cystic fibrosis and bone marrow transplant patients. Population Approach Group Europe: 15th Meeting, Bruges, Belgium, 14-16 June 2006. PAGE.
2006
Journal Article
Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria
Block, J. K., Vandemheen, K. L., Tullis, E., Fergusson, D., Doucette, S., Haase, D., Berthiaume, Y., Brown, N., Wilcox, P., Bye, P., Bell, S., Noseworthy, M., Pedder, L., Freitag, A. and Paterson, N. (2006). Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria. Thorax, 61 (11), 969-974. doi: 10.1136/thx.2006.061366
2006
Conference Publication
A D-optimal designed population pharmacokinetic study of itraconazole
Hennig, S, Wainwright, C E, Bell, S, Miller, H, Charles, B G and Duffull, S B (2006). A D-optimal designed population pharmacokinetic study of itraconazole. APSA Annual Meeting 2006, Adelaide, Australia, 2-5 December 2006. Adelaide:
2006
Conference Publication
Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients
Hennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients. The 6th Annual Health and Medical Research Conference of Queensland, Brisbane, Australia, 23-24 November 2006. Brisbane, Australia: Queensland Health.
2006
Conference Publication
A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis
Hennig, S., Wainwright, C. E., Bell, S., Miller, H., Charles, B. G. and Duffull, S. B. (2006). A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis. 15th Annual Meeting of the Population Approach Group in Europe, Bruges, Belgium, 14-16 June 2006. PAGE.
2006
Journal Article
Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients
Hennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006). Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients. Clinical Pharmacokinetics, 45 (11), 1099-1114. doi: 10.2165/00003088-200645110-00004
2005
Journal Article
Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions
Hill, Dominic, Rose, Barbara, Pajkos, Aniko, Robinson, Michael, Bye, Peter, Bell, Scott C., Elkins, Mark, Thompson, Barbara, MacLeod, Colin, Aaron, Shawn D. and Harbour, Colin (2005). Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. Journal of Clinical Microbiology, 43 (10), 5085-5090. doi: 10.1128/JCM.43.10.5085-5090.2005
Funding
Current funding
Supervision
Availability
- Professor Scott Bell is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Risk and mitigation of cough aerosols for people with cystic fibrosis.
Principal Advisor
Other advisors: Professor Rachel Thomson
-
Doctor Philosophy
The Pharmacokinetics & Pharmacodynamics of Antimycobacterial Drugs in People with Cystic Fibrosis and Drug-Resistant Tuberculosis Infection
Associate Advisor
Other advisors: Professor Rachel Thomson, Professor Jason Roberts
Completed supervision
-
2019
Doctor Philosophy
Impact of built environment, personal protective devices and ventilation on the dispersion of respiratory pathogens
Principal Advisor
-
2019
Master Philosophy
Infectious airborne transport in individuals with cystic fibrosis and mitigation strategies to reduce aerosol dispersal
Principal Advisor
-
2018
Doctor Philosophy
Diversity of environmental and clinical Pseudomonas aeruginosa isolates
Principal Advisor
Other advisors: Associate Professor David Whiley
-
2016
Doctor Philosophy
Heterogeneity within Pseudomonas aeruginosa shared strains in cystic fibrosis: the development and spread of antimicrobial resistance
Principal Advisor
Other advisors: Associate Professor David Whiley
-
2012
Doctor Philosophy
Diagnosis, epidemiology and population structure of Pseudomonas aeruginosa in cystic fibrosis.
Principal Advisor
-
2022
Doctor Philosophy
The effectiveness of ultraviolet C light at inactivating airborne Pseudomonas aeruginosa and Mycobacterium abscessus
Associate Advisor
-
2022
Doctor Philosophy
Deep Sequencing of Microbial Communities in Cystic Fibrosis Airways
Associate Advisor
Other advisors: Professor Ian Henderson
Media
Enquiries
For media enquiries about Professor Scott Bell's areas of expertise, story ideas and help finding experts, contact our Media team: